We are live on ! Find out more
BMCM

Bryn Mawr Capital Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+2.38%
1 Year Est. Return
+26.05%
3 Year Est. Return
+71.45%
5 Year Est. Return
+76.08%
10 Year Est. Return
AUM
$1.81B
AUM Growth
+$53.2M
Cap. Flow
-$42.9M
Cap. Flow %
-2.36%
Top 10 Hldgs %
32.01%
Holding
409
New
13
Increased
158
Reduced
148
Closed
22

Top Sells

Rank Stock Value
1
HSY icon
Hershey
HSY
+$48.2M
2
BA icon
Boeing
BA
+$13.4M
3
CME icon
CME Group
CME
+$5.88M
4
ALL icon
Allstate
ALL
+$5.2M
5
CLX icon
Clorox
CLX
+$4.3M

Sector Composition

Rank Sector Weight
1 Technology 21.86%
2 Healthcare 9.6%
3 Financials 7.47%
4 Consumer Discretionary 6.27%
5 Consumer Staples 5.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JCI icon
26
Johnson Controls International
JCI
$91.8B
$14.8M 0.82%
222,960
+3,987
+2% +$268K
SPY icon
27
State Street SPDR S&P 500 ETF Trust
SPY
$810B
$14.5M 0.8%
26,584
+649
+3% +$340K
GOOG icon
28
Alphabet (Google) Class C
GOOG
$4.32T
$14.4M 0.79%
78,479
-844
-1% -$144K
COWZ icon
29
Pacer US Cash Cows 100 ETF
COWZ
$19.5B
$13.8M 0.76%
251,421
+52,183
+26% +$2.9M
XOM icon
30
ExxonMobil
XOM
$661B
$13.7M 0.76%
119,228
+578
+0.5% +$67.3K
VIG icon
31
Vanguard Dividend Appreciation ETF
VIG
$114B
$13.1M 0.72%
71,752
-975
-1% -$175K
IBM icon
32
IBM
IBM
$222B
$13M 0.71%
74,171
+9,968
+16% +$1.73M
CVX icon
33
Chevron
CVX
$381B
$12.9M 0.71%
82,600
+425
+0.5% +$67.8K
KLAC icon
34
KLA
KLAC
$253B
$12.9M 0.71%
156,170
+620
+0.4% +$45.8K
TJX icon
35
TJX Companies
TJX
$177B
$12.6M 0.7%
114,570
+3,896
+4% +$392K
VYM icon
36
Vanguard High Dividend Yield ETF
VYM
$83.7B
$11.9M 0.66%
100,403
+4,684
+5% +$555K
MCD icon
37
McDonald's
MCD
$193B
$11.9M 0.65%
46,623
+1,326
+3% +$352K
GPC icon
38
Genuine Parts
GPC
$18.4B
$11.6M 0.64%
83,807
+1,199
+1% +$179K
PSX icon
39
Phillips 66
PSX
$85.1B
$11.1M 0.61%
78,804
-153
-0.2% -$22.6K
PEP icon
40
PepsiCo
PEP
$188B
$11M 0.6%
66,374
-394
-0.6% -$68K
MDT icon
41
Medtronic
MDT
$114B
$11M 0.6%
139,097
+3,971
+3% +$326K
MDLZ icon
42
Mondelez International
MDLZ
$78.4B
$10.9M 0.6%
167,187
+3,252
+2% +$223K
CME icon
43
CME Group
CME
$95.8B
$10.9M 0.6%
55,387
-28,454
-34% -$5.88M
ABT icon
44
Abbott
ABT
$188B
$10.8M 0.59%
103,772
+6,079
+6% +$645K
ACN icon
45
Accenture
ACN
$110B
$10.7M 0.59%
35,404
+751
+2% +$230K
IWX icon
46
iShares Russell Top 200 Value ETF
IWX
$4.05B
$10.4M 0.57%
138,582
+14,703
+12% +$1.1M
STZ icon
47
Constellation Brands
STZ
$22.8B
$10.3M 0.57%
40,050
+3,359
+9% +$864K
KDP icon
48
Keurig Dr Pepper
KDP
$39.9B
$10.2M 0.56%
306,860
+32,439
+12% +$1.08M
VGT icon
49
Vanguard Information Technology ETF
VGT
$148B
$10.1M 0.56%
139,808
-5,344
-4% -$355K
IWF icon
50
iShares Russell 1000 Growth ETF
IWF
$127B
$9.35M 0.52%
102,556
-1,520
-1% -$130K

Similar funds

Bryn Mawr Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Bryn Mawr Capital Management held 409 positions worth $1.81B, up 3% from $1.76B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Bryn Mawr Capital Management's Q2 2024 filing shows 13 new, 158 increased, 148 reduced and 22 closed positions. Its largest new stake was Nutrien: 91,371 shares worth $4.65M. The largest sale was Hershey, an estimated $48.2M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Bryn Mawr Capital Management's largest Q2 2024 buy was Nutrien: 91,371 shares worth $4.65M.
  • Bryn Mawr Capital Management added most to Apple in Q2 2024, an estimated $13.2M increase.
  • Bryn Mawr Capital Management's biggest Q2 2024 reduction was Hershey, cutting an estimated $48.2M.
  • Bryn Mawr Capital Management fully exited CVS Health in Q2 2024, selling an estimated $1.69M.
  • Bryn Mawr Capital Management's ten largest holdings make up 32% of its $1.81B portfolio in Q2 2024.
  • Bryn Mawr Capital Management opened 13 new positions and closed 22 in Q2 2024.
  • Bryn Mawr Capital Management's portfolio value rose 3% quarter-over-quarter to $1.81B.

Based on Bryn Mawr Capital Management's 13F filing for Q2 2024, filed 30 Jul 2024.